These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14978153)

  • 1. How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease?
    Pinkau T; Hilgers KF; Veelken R; Mann JF
    J Am Soc Nephrol; 2004 Mar; 15(3):517-23. PubMed ID: 14978153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiorenal disease: a clinical intersection.
    Kalra V; Mahajan S; Agarwal SK; Tiwari SC
    Int Urol Nephrol; 2005; 37(1):175-84. PubMed ID: 16132783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.
    Mann JF; Gerstein HC; Pogue J; Lonn E; Yusuf S
    Am J Cardiovasc Drugs; 2002; 2(3):157-62. PubMed ID: 14727978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular care in end-stage renal disease.
    McCullough PA
    Adv Chronic Kidney Dis; 2004 Jul; 11(3):245. PubMed ID: 15241738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk in patients with mild renal insufficiency.
    Mann JF; Gerstein HC; Dulau-Florea I; Lonn E
    Kidney Int Suppl; 2003 May; (84):S192-6. PubMed ID: 12694342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revascularization options in patients with chronic kidney disease.
    Ashrith G; Elayda MA; Wilson JM
    Tex Heart Inst J; 2010; 37(1):9-18. PubMed ID: 20200622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemfibrozil for secondary prevention of cardiovascular events in mild to moderate chronic renal insufficiency.
    Tonelli M; Collins D; Robins S; Bloomfield H; Curhan GC;
    Kidney Int; 2004 Sep; 66(3):1123-30. PubMed ID: 15327407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.
    Mann JF; Lonn EM; Yi Q; Gerstein HC; Hoogwerf BJ; Pogue J; Bosch J; Dagenais GR; Yusuf S;
    Kidney Int; 2004 Apr; 65(4):1375-80. PubMed ID: 15086477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of cardiovascular risk factors in chronic renal disease.
    Coresh J; Longenecker JC; Miller ER; Young HJ; Klag MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S24-30. PubMed ID: 11443765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
    Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular complications in patients with chronic renal insufficiency and chronic kidney failure].
    Tesar V
    Vnitr Lek; 2003 May; 49(5):383-7. PubMed ID: 12908173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and therapy of coronary artery disease in renal failure, end-stage renal disease, and renal transplant populations.
    Logar CM; Herzog CA; Beddhu S
    Am J Med Sci; 2003 Apr; 325(4):214-27. PubMed ID: 12695727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of chronic kidney disease in community-dwelling elderly and associated cardiovascular risk factors].
    Almirall J; Vaqueiro M; Antón E; Baré ML; González V; Jaimez E; Gimeno C;
    Nefrologia; 2005; 25(6):655-62. PubMed ID: 16514906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences.
    Ritz E; McClellan WM
    J Am Soc Nephrol; 2004 Mar; 15(3):513-6. PubMed ID: 14978152
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of proteinuria and prior cardiovascular disease in all major clinical outcomes of atherosclerotic renovascular disease - a single-center observational study.
    Vassallo D; Ritchie J; Green D; Chrysochou C; Blunt J; Kalra PA
    BMC Nephrol; 2016 Dec; 17(1):198. PubMed ID: 27927187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-stage renal disease and drug-eluting stents: one small step forward.
    Gruberg L; Beyar R
    J Invasive Cardiol; 2006 Sep; 18(9):409-10. PubMed ID: 16954578
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
    Anavekar NS; McMurray JJ; Velazquez EJ; Solomon SD; Kober L; Rouleau JL; White HD; Nordlander R; Maggioni A; Dickstein K; Zelenkofske S; Leimberger JD; Califf RM; Pfeffer MA
    N Engl J Med; 2004 Sep; 351(13):1285-95. PubMed ID: 15385655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease in end stage renal disease.
    Sharma R; Pellerin D; Brecker SJ
    Minerva Urol Nefrol; 2006 Jun; 58(2):117-31. PubMed ID: 16767066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential survival after coronary revascularization procedures among patients with renal insufficiency.
    Szczech LA; Reddan DN; Owen WF; Califf R; Racz M; Jones RH; Hannan EL
    Kidney Int; 2001 Jul; 60(1):292-9. PubMed ID: 11422764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis.
    Chang TI; Montez-Rath ME; Tsai TT; Hlatky MA; Winkelmayer WC
    J Am Coll Cardiol; 2016 Mar; 67(12):1459-1469. PubMed ID: 27012407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.